Scarica l'app Stockscreener
45.77
5.69%
-2.76
Pre-mercato:
46.66
0.89
+1.94%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Disc Medicine Inc Borsa (IRON) Ultime notizie
Teacher Retirement System of Texas Increases Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine is Now Oversold (IRON) - Nasdaq
Swiss National Bank Sells 2,600 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc medicine director Ashiya Mona sells shares worth $310,483 By Investing.com - Investing.com Canada
Orbimed advisors sells $310,483 in disc medicine stock By Investing.com - Investing.com Canada
Is Disc Medicine, Inc. (NASDAQ:IRON) the Best Small Cap Stock to Buy Before They Explode? - Insider Monkey
Orbimed advisors sells $310,483 in disc medicine stock - Investing.com India
Disc medicine director Ashiya Mona sells shares worth $310,483 - Investing.com India
10 Best Small-Cap Stocks to Buy Before They Explode - Insider Monkey
Raymond James Financial Inc. Purchases New Position in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
With 65% ownership, Disc Medicine, Inc. (NASDAQ:IRON) boasts of strong institutional backing - Yahoo
Disc Medicine, Inc. (NASDAQ:IRON) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World
Ashiya Mona sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com South Africa
OrbiMed Advisors sells $2.83 million in Disc Medicine stock By Investing.com - Investing.com Philippines
Orbimed Advisors LLC Reduces Stake in Disc Medicine Inc: Analyzi - GuruFocus
Ashiya Mona sells $2.83 million in Disc Medicine stock - Investing.com
OrbiMed Advisors sells $2.83 million in Disc Medicine stock - Investing.com
ORBIMED ADVISORS LLC Reduces Stake in Disc Medicine Inc - GuruFocus
Disc Medicine, Inc. (NASDAQ:IRON) Given Consensus Recommendation of “Buy” by Analysts - Defense World
Bank of New York Mellon Corp Buys 4,356 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential By Investing.com - Investing.com South Africa
Disc Medicine’s SWOT analysis: rare blood disorder biotech stock’s potential - Investing.com
Disc Medicine (NASDAQ:IRON) Given New $132.00 Price Target at Cantor Fitzgerald - Defense World
Arizona State Retirement System Has $300,000 Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
All You Need to Know About Disc Medicine, Inc. (IRON) Rating Upgrade to Buy - Yahoo Finance
Disc Medicine (IRON) to Release Quarterly Earnings on Thursday - Defense World
Disc medicine director Ashiya Mona sells $16.97 million in stock By Investing.com - Investing.com South Africa
Orbimed advisors sells $16.97 million in disc medicine shares By Investing.com - Investing.com Australia
Disc Medicine’s SWOT analysis: stock poised for growth amid clinical milestones By Investing.com - Investing.com South Africa
Disc medicine director Ashiya Mona sells $16.97 million in stock - Investing.com India
Disc Medicine’s SWOT analysis: stock poised for growth amid clinical milestones - Investing.com India
Orbimed advisors sells $16.97 million in disc medicine shares - Investing.com India
Disc Medicine’s (IRON) Overweight Rating Reiterated at Morgan Stanley - Defense World
Certain Stock Options of Disc Medicine, Inc. are subject to a Lock-Up Agreement Ending on 9-MAR-2025. - Marketscreener.com
FY2025 EPS Forecast for Disc Medicine Increased by Analyst - Defense World
Disc Medicine (NASDAQ:IRON) Given New $75.00 Price Target at Scotiabank - MarketBeat
New York State Common Retirement Fund Cuts Stake in Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Rhumbline Advisers Purchases 1,553 Shares of Disc Medicine, Inc. (NASDAQ:IRON) - Defense World
Disc Medicine (NASDAQ:IRON) Price Target Raised to $75.00 at Scotiabank - Defense World
1.23%
1.63%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):